122 related articles for article (PubMed ID: 1849934)
1. The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent.
Aiba S; Katz SI
J Immunol; 1991 Apr; 146(8):2479-87. PubMed ID: 1849934
[TBL] [Abstract][Full Text] [Related]
2. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
Streilein JW; Grammer SF
J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763
[TBL] [Abstract][Full Text] [Related]
3. Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.
Girolomoni G; Valle MT; Zacchi V; Costa MG; Giannetti A; Manca F
Immunology; 1996 Feb; 87(2):310-6. PubMed ID: 8698396
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen.
Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI
J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
6. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.
Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA
J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
Del Pozo V; De Andrés B; Martín E; Cárdaba B; Fernández JC; Gallardo S; Tramón P; Leyva-Cobian F; Palomino P; Lahoz C
Eur J Immunol; 1992 Jul; 22(7):1919-25. PubMed ID: 1623930
[TBL] [Abstract][Full Text] [Related]
8. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
9. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
10. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
Moreno J; Adorini L; Hämmerling GJ
J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
[TBL] [Abstract][Full Text] [Related]
11. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
Will A; Blank C; Röllinghoff M; Moll H
Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029
[TBL] [Abstract][Full Text] [Related]
12. Characterization of autoreactive T cells. Relative importance of self-peptides versus MHC.
Wang YS; Perkins DL
J Immunol; 1991 Aug; 147(3):804-9. PubMed ID: 1861076
[TBL] [Abstract][Full Text] [Related]
13. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
St-Pierre Y; Watts TH
J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
[TBL] [Abstract][Full Text] [Related]
14. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
15. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
[TBL] [Abstract][Full Text] [Related]
16. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
17. Antigen-presenting cell-T cell interaction in the chicken is MHC class II antigen restricted.
Vainio O; Veromaa T; Eerola E; Toivanen P; Ratcliffe MJ
J Immunol; 1988 May; 140(9):2864-8. PubMed ID: 3258887
[TBL] [Abstract][Full Text] [Related]
18. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants.
Dang LH; Michalek MT; Takei F; Benaceraff B; Rock KL
J Immunol; 1990 Jun; 144(11):4082-91. PubMed ID: 1971292
[TBL] [Abstract][Full Text] [Related]
19. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
